IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 325 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $404,362 | -100.0% | 11,314 | -50.9% | 0.00% | -75.0% |
Q3 2022 | $1,018,307,000 | -29.7% | 23,023 | -41.1% | 0.01% | -38.5% |
Q2 2022 | $1,447,852,000 | -12.6% | 39,110 | -12.5% | 0.01% | -7.1% |
Q1 2022 | $1,656,391,000 | +93.7% | 44,719 | +59.1% | 0.01% | +133.3% |
Q4 2021 | $855,326,000 | -24.2% | 28,108 | +18.2% | 0.01% | -57.1% |
Q3 2020 | $1,128,503,000 | +72008.8% | 23,783 | -28.2% | 0.01% | -41.7% |
Q1 2020 | $1,565,000 | -59.6% | 33,111 | -48.3% | 0.02% | -22.6% |
Q4 2019 | $3,871,000 | +14.6% | 64,088 | +13.6% | 0.03% | +3.3% |
Q3 2019 | $3,379,000 | -48.3% | 56,406 | -44.5% | 0.03% | -49.2% |
Q2 2019 | $6,533,000 | +87.9% | 101,649 | +137.4% | 0.06% | +90.3% |
Q1 2019 | $3,476,000 | +220.7% | 42,821 | +103.7% | 0.03% | +416.7% |
Q3 2018 | $1,084,000 | +300.0% | 21,024 | +242.4% | 0.01% | +200.0% |
Q1 2018 | $271,000 | -82.2% | 6,140 | -79.6% | 0.00% | -81.8% |
Q3 2017 | $1,523,000 | -65.6% | 30,038 | -65.5% | 0.01% | -69.4% |
Q2 2017 | $4,432,000 | +2105.0% | 87,120 | +1974.3% | 0.04% | +1700.0% |
Q4 2016 | $201,000 | -70.6% | 4,200 | -77.5% | 0.00% | -66.7% |
Q3 2016 | $683,000 | -69.7% | 18,638 | -80.7% | 0.01% | -71.4% |
Q2 2016 | $2,252,000 | -63.8% | 96,664 | -37.0% | 0.02% | -65.6% |
Q1 2016 | $6,215,000 | -23.5% | 153,486 | +17.0% | 0.06% | -27.4% |
Q4 2015 | $8,121,000 | – | 131,148 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |